Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.

Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.

Show other versions (1)

Bioenergetic abnormalities and metabolic dysfunction occur in amyotrophic lateral sclerosis (ALS) patients and genetic mouse models. However, whether metabolic dysfunction occurs early in ALS pathophysiology linked to different ALS genes remains unclear. Here, we investigated AMP-activated protein k...

Full description

Bibliographic Details
Main Authors:	Nirma D Perera, Rebecca K Sheean, John W Scott, Bruce E Kemp, Malcolm K Horne, Bradley J Turner
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3989332?pdf=render

Similar Items

Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.
by: Nirma D Perera, et al.
Published: (2014-01-01)

ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation.
by: Adam K Walker, et al.
Published: (2013-01-01)

Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice
by: Nirma D. Perera, et al.
Published: (2021-07-01)

Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling.
by: Simon D'Alton, et al.
Published: (2014-01-01)

The role of adiponectin-AMPK axis in TDP-43 mislocalization and disease severity in ALS
by: Yu-Ju Liu, et al.
Published: (2024-11-01)

Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation
by: N. Kreiter, et al.
Published: (2018-07-01)

Aberrant TDP‐43 phosphorylation: a key wind gap from TDP‐43 to TDP‐43 proteinopathy
by: Zi‐Qi Huang, et al.
Published: (2021-06-01)

Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP
by: Feneberg, E, et al.
Published: (2021)

TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Lumi Zhang, et al.
Published: (2020-01-01)

Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice
by: Dickson Dennis W, et al.
Published: (2011-10-01)

Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo
by: Hibiki Kawamata, et al.
Published: (2017-05-01)

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
by: Sarah Pickles, et al.
Published: (2022-07-01)

ALS-linked TDP-43M337V knock-in mice exhibit splicing deregulation without neurodegeneration
by: Seiji Watanabe, et al.
Published: (2020-01-01)

LIPIDS ALTERATION IN TDP-43
by: Irene García Toledo, et al.
Published: (2023-10-01)

The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation
by: Juan Carlos Rengifo-Gonzalez, et al.
Published: (2021-09-01)

TDP-43: From Alzheimer’s Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Wendi Huang, et al.
Published: (2020-02-01)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
by: Rachel Atkinson, et al.
Published: (2021-02-01)

Towards a TDP-43-based biomarker for ALS and FTLD
by: Feneberg, E, et al.
Published: (2018)

Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy.
by: Angela S Laird, et al.
Published: (2010-10-01)

Age-related deregulation of TDP-43 after stroke enhances NF-κB-mediated inflammation and neuronal damage
by: Sai Sampath Thammisetty, et al.
Published: (2018-11-01)

The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43.
by: Ya-Fei Xu, et al.
Published: (2013-01-01)

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
by: Yuting Ren, et al.
Published: (2021-06-01)

Mechanisms and models of TDP-43 proteinopathies
by: Petrucelli Leonard
Published: (2012-02-01)

TDP-43 Pathology in Alzheimer’s Disease
by: Axel Meneses, et al.
Published: (2021-12-01)

RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
by: Julie C Necarsulmer, et al.
Published: (2023-10-01)

Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies
by: Yohei Iguchi, et al.
Published: (2012-03-01)

Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology
by: Yuan Tian, et al.
Published: (2021-12-01)

Molecular fragment characteristics and distribution of tangle associated TDP-43 (TATs) and other TDP-43 lesions in Alzheimer’s disease
by: Keith Anthony Josephs, et al.
Published: (2023-12-01)

Cytotoxic immune cells do not affect TDP-43 and p62 sarcoplasmic aggregation but influence TDP-43 localisation
by: Bryony McCord, et al.
Published: (2023-09-01)

High glycine content in TDP-43: a potential culprit in limbic-predominant age-related TDP-43 encephalopathy
by: Shanshan An, et al.
Published: (2020-06-01)

Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice
by: Xuebing Ding, et al.
Published: (2021-01-01)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
by: Ansorge Olaf, et al.
Published: (2008-10-01)

Investigating TDP43 biological dysfunction through the characterisation of Tardbp ENU mouse mutants: implications for neurodegeneration
by: De Sao Jose Martinho De Oliveira, H, et al.
Published: (2014)

ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice
by: Mai Horiuchi, et al.
Published: (2024-11-01)

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
by: Britt A. Berning, et al.
Published: (2019-04-01)

Implications of TDP-43 in non-neuronal systems
by: Hao Ke, et al.
Published: (2023-11-01)

TDP-43 Proteinopathy Specific Biomarker Development
by: Isabell Cordts, et al.
Published: (2023-02-01)

Propagation of TDP-43 proteinopathy in neurodegenerative disorders
by: Rachel Keszycki, et al.
Published: (2022-01-01)

TDP-43 overexpression impairs presynaptic integrity
by: Lanier Heyburn, et al.
Published: (2016-01-01)

Inflammation Induces TDP-43 Mislocalization and Aggregation.
by: Ana Sofia Correia, et al.
Published: (2015-01-01)